Literature DB >> 10697022

The cancer anorexia-cachexia syndrome.

K A Nelson1.   

Abstract

The cancer anorexia-cachexia syndrome is one of the most common causes of death among cancer patients and is present in 80% at death. It is a complex example of metabolic chaos effecting protein, carbohydrate, and fat metabolism. Tumors produce both direct and indirect abnormalities, resulting in anorexia and weight loss. The disease burden does not correlate with the degree of cachexia. Although there is no treatment to control or reverse the process, appetite stimulants may promote increased food intake and enhance quality of life.

Entities:  

Mesh:

Year:  2000        PMID: 10697022

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  19 in total

Review 1.  Outcome research in palliative care: could it represent a new dimension of clinical research or clinical practice?

Authors:  Davide Tassinari; Marco Maltoni; Sergio Sartori; Manuela Fantini; Barbara Poggi; Alberto Ravaioli
Journal:  Support Care Cancer       Date:  2004-12-03       Impact factor: 3.603

Review 2.  Managing cancer-related anorexia/cachexia.

Authors:  G Mantovani; A Macciò; E Massa; C Madeddu
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway.

Authors:  Carlos Camps; Vega Iranzo; Roy M Bremnes; Rafael Sirera
Journal:  Support Care Cancer       Date:  2006-07-04       Impact factor: 3.603

4.  Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire.

Authors:  J M Ribaudo; D Cella; E A Hahn; S R Lloyd; N S Tchekmedyian; J Von Roenn; W T Leslie
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

Review 5.  Cancer cachexia, mechanism and treatment.

Authors:  Tomoyoshi Aoyagi; Krista P Terracina; Ali Raza; Hisahiro Matsubara; Kazuaki Takabe
Journal:  World J Gastrointest Oncol       Date:  2015-04-15

Review 6.  Thalidomide in cancer treatment: a potential role in the elderly?

Authors:  Shufeng Zhou; Philip Kestell; Malcolm D Tingle; James W Paxton
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 7.  Symptom management challenges in heart failure: pharmacotherapy considerations.

Authors:  Diana Stewart; Mary Lynn McPherson
Journal:  Heart Fail Rev       Date:  2017-09       Impact factor: 4.214

8.  Disruptions in the organization of meal preparation and consumption among older cancer patients and their family caregivers.

Authors:  Julie L Locher; Caroline O Robinson; F Amos Bailey; William R Carroll; Douglas C Heimburger; M Wasif Saif; Gabriel Tajeu; Christine S Ritchie
Journal:  Psychooncology       Date:  2010-09       Impact factor: 3.894

9.  The contribution of social factors to undereating in older adults with cancer.

Authors:  Julie L Locher; Caroline O Robinson; F Amos Bailey; William R Carroll; Douglas C Heimburger; J Scott Magnuson; M Wasif Saif; Christine S Ritchie
Journal:  J Support Oncol       Date:  2009 Sep-Oct

10.  Evaluation of nutritional status in advanced metastatic cancer.

Authors:  N Sarhill; F Mahmoud; D Walsh; K A Nelson; S Komurcu; M Davis; S LeGrand; O Abdullah; L Rybicki
Journal:  Support Care Cancer       Date:  2003-08-15       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.